Rapport Therapeutics, Inc. Contracts & Agreements

13 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Option and License Agreement, by and between the Registrant and Janssen Pharmaceutica NV, dated August 9, 2022, as amended
License Agreements
Rapport Therapeutics, Inc.
Health Care Equipment & Supplies
NY
2024
Employment Agreement, by and between the Company and Abraham N. Ceesay, M.B.A., effective as of June 10, 2024
Employment Agreements
Rapport Therapeutics, Inc.
2024
Employment Agreement, by and between the Company and Troy Ignelzi, effective as of June 10, 2024
Employment Agreements
Rapport Therapeutics, Inc.
2024
Employment Agreement, by and between the Company and Cheryl Gault, effective as of June 10, 2024
Employment Agreements
Rapport Therapeutics, Inc.
2024
Form of Stock Purchase Agreement, by and among the Company and the Purchasers
Stock Agreements
Rapport Therapeutics, Inc.
2024
Specimen Common Stock Certificate
Stock Agreements
Rapport Therapeutics, Inc.
2024
Amended and Restated Investors Rights Agreement, by and between the Registrant and certain of its stockholders, dated as of August 7, 2023
Investor Rights Agreements
Rapport Therapeutics, Inc.
2024
2022 Stock Option and Grant Plan, as amended, and form of award agreements thereunder
Stock Agreements
Rapport Therapeutics, Inc.
2024
Master Services Agreement, by and between the Registrant and NeuroPace Inc., dated November 28, 2023
Services Agreements
Rapport Therapeutics, Inc.
2024
Statement of Work #1, by and between the Registrant and NeuroPace Inc., dated November 28, 2023, as amended March 1, 2024
Rapport Therapeutics, Inc.
2024
Sublease Agreement, by and between the Registrant and Whoop, Inc., dated June 15, 2023
Lease Agreements
Rapport Therapeutics, Inc.
2024
License Agreement, by and between the Registrant and ARE-SD Region No. 61, LLC, dated December 21, 2023
License Agreements
Rapport Therapeutics, Inc.
2024
Lease Agreement, by and between the Registrant and ARE-9880 Campus Point, LLC, dated February 12, 2024
Lease Agreements
Rapport Therapeutics, Inc.
2024